| Product Code: ETC6359184 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Neuropathic Pain Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Neuropathic Pain Market - Industry Life Cycle |
3.4 Belgium Neuropathic Pain Market - Porter's Five Forces |
3.5 Belgium Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Belgium Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Belgium Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Belgium Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Belgium Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 Belgium Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 Belgium Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 Belgium Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases leading to neuropathic pain |
4.2.2 Growing geriatric population in Belgium |
4.2.3 Advancements in medical technology for the diagnosis and treatment of neuropathic pain |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines governing the approval and commercialization of neuropathic pain treatments |
4.3.2 High costs associated with neuropathic pain medications and therapies |
4.3.3 Limited awareness among healthcare professionals and patients about neuropathic pain management options |
5 Belgium Neuropathic Pain Market Trends |
6 Belgium Neuropathic Pain Market, By Types |
6.1 Belgium Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Belgium Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 Belgium Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 Belgium Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 Belgium Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Belgium Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 Belgium Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Belgium Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 Belgium Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Belgium Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 Belgium Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 Belgium Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 Belgium Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 Belgium Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 Belgium Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 Belgium Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 Belgium Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 Belgium Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 Belgium Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 Belgium Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 Belgium Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 Belgium Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 Belgium Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 Belgium Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 Belgium Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 Belgium Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 Belgium Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 Belgium Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 Belgium Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 Belgium Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 Belgium Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 Belgium Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 Belgium Neuropathic Pain Market Import-Export Trade Statistics |
7.1 Belgium Neuropathic Pain Market Export to Major Countries |
7.2 Belgium Neuropathic Pain Market Imports from Major Countries |
8 Belgium Neuropathic Pain Market Key Performance Indicators |
8.1 Average time to diagnosis of neuropathic pain in Belgium |
8.2 Number of healthcare providers specializing in neuropathic pain treatment |
8.3 Patient satisfaction with neuropathic pain management services |
9 Belgium Neuropathic Pain Market - Opportunity Assessment |
9.1 Belgium Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Belgium Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Belgium Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Belgium Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Belgium Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 Belgium Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 Belgium Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 Belgium Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Belgium Neuropathic Pain Market - Competitive Landscape |
10.1 Belgium Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 Belgium Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here